Display options
Cite
Martocchia A, Bruscia C, Conforti G, et al. Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN. SN Compr Clin Med. 2021;4(1):3doi: 10.1007/s42399-021-01079-9.
Martocchia, A., Bruscia, C., Conforti, G., Falangone, F., Marini, V., Pennica, A., Pezzuto, A., March, M. R., Sentimentale, A., Spuntarelli, V., Tafaro, L., Ricci, A., Simmaco, M., Sesti, G., Preissner, R., & Martelletti, P. (2021). Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN. SN comprehensive clinical medicine, 4(1), 3. https://doi.org/10.1007/s42399-021-01079-9
Martocchia, Antonio, et al. "Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN." SN comprehensive clinical medicine vol. 4,1 (2021): 3. doi: https://doi.org/10.1007/s42399-021-01079-9
Martocchia A, Bruscia C, Conforti G, Falangone F, Marini V, Pennica A, Pezzuto A, March MR, Sentimentale A, Spuntarelli V, Tafaro L, Ricci A, Simmaco M, Sesti G, Preissner R, Martelletti P. Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN. SN Compr Clin Med. 2021;4(1):3. doi: 10.1007/s42399-021-01079-9. Epub 2021 Dec 27. PMID: 34977463; PMCID: PMC8710931.
Copy Download .nbib Format: NLM
Share it on

SN Compr Clin Med. 2021;4(1):3. doi: 10.1007/s42399-021-01079-9. Epub 2021 Dec 27.

Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN.

SN comprehensive clinical medicine

Antonio Martocchia, Clara Bruscia, Giulia Conforti, Francesca Falangone, Valentina Marini, Alfredo Pennica, Aldo Pezzuto, Massimiliano Rocchietti March, Alberto Sentimentale, Valerio Spuntarelli, Laura Tafaro, Alberto Ricci, Maurizio Simmaco, Giorgio Sesti, Robert Preissner, Paolo Martelletti

Affiliations

  1. Sant'Andrea Hospital, Sapienza University of Rome, Via di Grottarossa 1032, 00189 Rome, Italy.
  2. Institute of Physiology and Science-IT, Charité-Universitätsmedizin Berlin, Corporate Member of Freie, Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany.

PMID: 34977463 PMCID: PMC8710931 DOI: 10.1007/s42399-021-01079-9

Abstract

The coronavirus disease 19 (COVID-19) infection requires major efforts in healthcare systems, due to the high risk of mortality, particularly in subjects with significant comorbidity (≥ 2 pathologies) and polypharmacy (≥ 5 drugs). The treatment of COVID-19 needs a careful evaluation, to reduce the risk of potentially adverse drug reactions. The aim of the study was to examine the use of computerized prescription support in the management and treatment of the COVID-19 infection. We evaluated n.33 patients (51% females) admitted to the west COVID Low-Medium Intensity of Care of Sant'Andrea Hospital during the period March-April 2020 and n.42 subjects (50% females) admitted to the Internal Medicine ward (as control group), by INTERCheck® and Drug-PIN®. The comorbidity (n. pathologies), polypharmacy (n. drugs), and total INTERCheck score in COVID-19 patients and controls were, respectively (mean ± standard deviation): 5.8 ± 3.8, 7.9 ± 4.5, and 9.2 ± 7.1 and 6.8 ± 2.6, 8.0 ± 2.6, and 4.9 ± 3.8 (statistically significant for comorbidity

© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021.

Keywords: COVID-19; Comorbidity; Drug-PIN; INTERCheck; Polypharmacy

Conflict of interest statement

Conflict of InterestThe authors declare no competing interests.

References

  1. JAMA. 2020 Apr 7;323(13):1239-1242 - PubMed
  2. N Engl J Med. 2020 Feb 20;382(8):727-733 - PubMed
  3. Intern Emerg Med. 2018 Dec;13(8):1191-1200 - PubMed
  4. J Am Geriatr Soc. 1968 May;16(5):622-6 - PubMed
  5. SN Compr Clin Med. 2021 Jan 27;:1-7 - PubMed
  6. SN Compr Clin Med. 2020 Apr 1;:1-2 - PubMed
  7. Arch Gerontol Geriatr. 2009 Jul-Aug;49(1):150-2 - PubMed
  8. SN Compr Clin Med. 2021 Jan 11;:1-11 - PubMed
  9. Ther Clin Risk Manag. 2020 Oct 20;16:1007-1022 - PubMed
  10. Ann Intern Med. 2009 May 5;150(9):604-12 - PubMed
  11. Eur J Intern Med. 2015 Nov;26(9):e52-3 - PubMed
  12. Intern Emerg Med. 2020 Nov;15(8):1467-1476 - PubMed
  13. Intern Emerg Med. 2021 Apr;16(3):697-710 - PubMed
  14. PLoS One. 2012;7(12):e51020 - PubMed
  15. Int J Antimicrob Agents. 2020 Jul;56(1):105949 - PubMed
  16. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43 - PubMed
  17. SN Compr Clin Med. 2020 Jul 28;:1-6 - PubMed
  18. Drugs Real World Outcomes. 2020 Sep;7(3):243-249 - PubMed
  19. SN Compr Clin Med. 2020 May 29;:1-6 - PubMed
  20. Aging (Albany NY). 2020 Jul 13;12(13):12493-12503 - PubMed
  21. Nucleic Acids Res. 2014 Jan;42(Database issue):D1113-7 - PubMed
  22. Pharmaceuticals (Basel). 2021 Jan 15;14(1): - PubMed
  23. Drugs Aging. 2020 Dec;37(12):925-933 - PubMed
  24. BMC Geriatr. 2017 Oct 10;17(1):230 - PubMed
  25. J Pers Med. 2021 May 18;11(5): - PubMed
  26. SN Compr Clin Med. 2020 Jun 29;:1-4 - PubMed
  27. SN Compr Clin Med. 2020 Apr 8;:1-2 - PubMed

Publication Types